Analyst Research

Report Title Price
Provider: ValuEngine, Inc.
Provider: Reuters Investment Profile
Provider: Edison Investment Research
Provider: Plunkett Research, Ltd.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

iCo Therapeutics Inc Closes $3.4 Million Financing

Tuesday, 21 May 2013 08:56am EDT 

iCo Therapeutics Inc announced that overnight marketed offering (the Offering). Under the Offering 9,655,771 units (Units) were priced at $0.35 per Unit for aggregate gross proceeds of $3,379,519.90. Each Unit is comprised of one common share of the Company (a Common Share) and one common share purchase warrant (a Warrant). Each Warrant entitles the holder to acquire one Common Share at a price of $0.40 per share for a period of five years following closing of the Offering. The Units were issued pursuant to an agency agreement between the Company and Euro Pacific Canada Inc. (the Agent). The Agent appointed a soliciting dealer group of other registered dealers including H.C. Wainwright & Co. LLC and Bloom Burton & Co. (together with the Agent, the Selling Group) for the purpose of arranging the purchase of Units under the Offering. H.C. Wainwright & Co. LLC acted as lead U.S. placement agent. 

Company Quote

0.0 +0.00%
15 Sep 2014